Close Menu

You may find more results for this query on our sister sites: GenomeWeb and Precision Oncology News.

Home › Tools & Technology › PCR › Cepheid Wins FDA Approval for Xpress Flu, Flu/RSV Tests

Cepheid Wins FDA Approval for Xpress Flu, Flu/RSV Tests

Feb 15, 2017

NEW YORK (GenomeWeb) – Cepheid's Xpert Xpress Flu and Xpert Xpress Flu/RSV tests have received clearance from the US Food and Drug Administration, the firm announced today.

The tests are the first in the firm's planned line of Xpress branded tests — faster versions of the firm's Xpert test cartridges enabling test times of 30 minutes or less.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Sep
30
Featured Webinar

Moving from Non-Invasive Prenatal Screening to Prenatal Diagnostics: An Expert Panel Discussion

Sponsored by
LGC SeraCare Life Sciences

Non-invasive prenatal testing (NIPT) continues to expand globally to support maternal-fetal patient care. 

What's Popular?

In PCR

  1. FDA Publishes First Batch of SARS-CoV-2 MDx Limit of Detection Comparison Results

    Premium

  2. Promega to Develop MSI Assay as CDx for Incyte Endometrial Cancer Drug

  3. FDA Grants Emergency Use Authorization for GK Pharmaceuticals Coronavirus Test

  4. FDA Grants Emergency Use Authorization to Coronavirus Tests From Visby Medical, SNIBE

  5. DiaSorin Receives CE Mark to Use Saliva Samples With COVID-19 Test

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2020 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.